Breakthrough in Malaria detection: new FREM platform delivers 98% accuracy for rapid screening and genotyping

The Flexible, Robust, Equipment-free Microfluidic (FREM) platform for malaria screening and Plasmodium species genotyping.

Brain Impairment Persists at Least 18 Months After COVID Hospitalization

Cognition was impaired for at least a year and a half after severe SARS-CoV-2 infection, but overall cognitive problems were like those seen in patients

December 29, 2023

Novartis turns to BioAge for new targets based on longevity and exercise

BioAge Labs, which began nearly a decade ago as an anti-aging biotech and then turned to obesity this year, is going back to its roots

December 19, 2024

Organon and Sempre Health announce collaboration on new service to help eligible patients save money and stay on their medication as prescribed

Organon (NYSE:OGN) and Sempre Health today announced a strategic partnership designed to motivate eligible patients to refill their prescriptions on time and improve adherence through

November 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.